160 related articles for article (PubMed ID: 31760309)
1. Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study.
Loopik DL; IntHout J; Melchers WJG; Massuger LFAG; Bekkers RLM; Siebers AG
Eur J Cancer; 2020 Jan; 124():102-109. PubMed ID: 31760309
[TBL] [Abstract][Full Text] [Related]
2. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
Vessey MP; Lawless M; McPherson K; Yeates D
Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
[TBL] [Abstract][Full Text] [Related]
3. Risk of precancerous cervical lesions in women using a hormone-containing intrauterine device and other contraceptives: a register-based cohort study from Denmark.
Skorstengaard M; Lynge E; Napolitano G; Blaakær J; Bor P
Hum Reprod; 2021 Jun; 36(7):1796-1807. PubMed ID: 33974685
[TBL] [Abstract][Full Text] [Related]
4. The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.
Roura E; Travier N; Waterboer T; de Sanjosé S; Bosch FX; Pawlita M; Pala V; Weiderpass E; Margall N; Dillner J; Gram IT; Tjønneland A; Munk C; Palli D; Khaw KT; Overvad K; Clavel-Chapelon F; Mesrine S; Fournier A; Fortner RT; Ose J; Steffen A; Trichopoulou A; Lagiou P; Orfanos P; Masala G; Tumino R; Sacerdote C; Polidoro S; Mattiello A; Lund E; Peeters PH; Bueno-de-Mesquita HB; Quirós JR; Sánchez MJ; Navarro C; Barricarte A; Larrañaga N; Ekström J; Lindquist D; Idahl A; Travis RC; Merritt MA; Gunter MJ; Rinaldi S; Tommasino M; Franceschi S; Riboli E; Castellsagué X
PLoS One; 2016; 11(1):e0147029. PubMed ID: 26808155
[TBL] [Abstract][Full Text] [Related]
5. The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: A population-based cohort study with 80,442 women.
Loopik DL; IntHout J; Ebisch RMF; Melchers WJG; Massuger LFAG; Siebers AG; Bekkers RLM
Gynecol Oncol; 2020 Apr; 157(1):195-201. PubMed ID: 31973912
[TBL] [Abstract][Full Text] [Related]
6. The relationship between hormonal contraception and cervical dysplasia/cancer controlling for human papillomavirus infection: A systematic review.
Anastasiou E; McCarthy KJ; Gollub EL; Ralph L; van de Wijgert JHHM; Jones HE
Contraception; 2022 Mar; 107():1-9. PubMed ID: 34752778
[TBL] [Abstract][Full Text] [Related]
7. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D
BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858
[TBL] [Abstract][Full Text] [Related]
8. The risk of cervical atypia in oral contraceptive users.
Adhikari I; Eriksson T; Luostarinen T; Lehtinen M; Apter D
Eur J Contracept Reprod Health Care; 2018 Feb; 23(1):12-17. PubMed ID: 29412045
[TBL] [Abstract][Full Text] [Related]
9. Hormonal contraceptive use and smoking as risk factors for high-grade cervical intraepithelial neoplasia in unvaccinated women aged 30-44 years: A case-control study in New South Wales, Australia.
Xu H; Egger S; Velentzis LS; O'Connell DL; Banks E; Darlington-Brown J; Canfell K; Sitas F
Cancer Epidemiol; 2018 Aug; 55():162-169. PubMed ID: 29980028
[TBL] [Abstract][Full Text] [Related]
10. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
Kjær SK; Frederiksen K; Munk C; Iftner T
J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
[TBL] [Abstract][Full Text] [Related]
11. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
[TBL] [Abstract][Full Text] [Related]
12. Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3-A Danish nationwide cohort study.
Sand FL; Frederiksen K; Munk C; Jensen SM; Kjaer SK
Int J Cancer; 2018 May; 142(9):1759-1766. PubMed ID: 29218720
[TBL] [Abstract][Full Text] [Related]
13. Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology.
Castle PE; Walker JL; Schiffman M; Wheeler CM
Int J Cancer; 2005 Dec; 117(6):1007-12. PubMed ID: 15986443
[TBL] [Abstract][Full Text] [Related]
14. Recent intrauterine device use and the risk of precancerous cervical lesions and cervical cancer.
Averbach S; Silverberg MJ; Leyden W; Smith-McCune K; Raine-Bennett T; Sawaya GF
Contraception; 2018 Apr; ():. PubMed ID: 29673740
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of high-risk HPV and cervical dysplasia in IUD users and controls: a cross sectional study.
Jans L; Brynhildsen J; Cherif E; Tenerz L; Bergengren L
Eur J Contracept Reprod Health Care; 2024 Jun; 29(3):109-114. PubMed ID: 38666336
[TBL] [Abstract][Full Text] [Related]
16. Risks of cervical intraepithelial neoplasia grade 3 or invasive cancers in ASCUS women with different management: a population-based cohort study.
Tai YJ; Chen YY; Hsu HC; Chiang CJ; You SL; Chen CA; Cheng WF;
J Gynecol Oncol; 2018 Jul; 29(4):e55. PubMed ID: 29770625
[TBL] [Abstract][Full Text] [Related]
17. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
Lopez LM; Chen M; Mullins S; Curtis KM; Helmerhorst FM
Cochrane Database Syst Rev; 2012 Aug; (8):CD009849. PubMed ID: 22895991
[TBL] [Abstract][Full Text] [Related]
18. Contraceptive choice and prevalence of cervical dysplasia and carcinoma in situ.
Ory H; Naib Z; Conger SB; Hatcher RA; Tyler CW
Am J Obstet Gynecol; 1976 Mar; 124(6):573-7. PubMed ID: 1258912
[TBL] [Abstract][Full Text] [Related]
19. Long-Lasting Increased Risk of Human Papillomavirus-Related Carcinomas and Premalignancies After Cervical Intraepithelial Neoplasia Grade 3: A Population-Based Cohort Study.
Ebisch RMF; Rutten DWE; IntHout J; Melchers WJG; Massuger LFAG; Bulten J; Bekkers RLM; Siebers AG
J Clin Oncol; 2017 Aug; 35(22):2542-2550. PubMed ID: 28541790
[TBL] [Abstract][Full Text] [Related]
20. The relative risk of noncervical high-risk human papillomavirus-related (pre)malignancies after recurrent cervical intraepithelial neoplasia grade 3: A population-based study.
Loopik DL; Ebisch RM; IntHout J; Melchers WJ; Massuger LF; Bekkers RL; Siebers AG
Int J Cancer; 2020 Aug; 147(3):897-900. PubMed ID: 31846057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
